Orbimed Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 6,475,291 shares of PMVP stock, worth $8.68 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
6,475,291
Previous 6,475,291
-0.0%
Holding current value
$8.68 Million
Previous $9.78 Million
27.81%
% of portfolio
0.22%
Previous 0.26%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
62Shares Held
40.4MCall Options Held
1.8KPut Options Held
100-
Bml Capital Management, LLC Zionsville, IN3.75MShares$5.02 Million3.31% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.01 Million1.53% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.31MShares$4.43 Million0.07% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.3MShares$4.42 Million0.29% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.52 Million1.08% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $61.1M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...